Home › Cancer (all types) › NCT07352579

From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:

  * Provide informed consent via check box for survey
  * Provide verbal consent via Zoom for interview
  * Must be able to read and understand English
  * Willing to comply with all study procedures and be available for the duration of the study
  * Patients with existing HRSN data in their EHR that answere4d yes to risk in at least one domain and no to wanting help/follow up

Exclusion Criteria:

* An individual who meets any of the following criteria will be excluded from participation in this study:

  * If they do not consent
  * Non-patients with existing HRSN data in their EHR
  * Individuals unable to complete the survey due to language barriers or other cognitive limitations

About the study

This observational study aims to identify the factors that influence whether cancer patients accept or decline supportive care services after screening positive for health-related social needs (HRSNs) at the Sidney Kimmel Comprehensive Cancer Center.

The study focuses on adult oncology patients who previously reported at least one HRSN-such as transportation, food, housing, or utility needs-but declined assistance when it was offered.

The main questions it aims to answer are:

* What factors shape cancer patients' intentions to use supportive care services for HRSNs? * Why do patients who screen positive for HRSNs choose not to accept help offered by the healthcare system?

Participants will:

* Complete a one-time electronic survey delivered via MyChart or email. * Optionally participate in a semi-structured Zoom interview (for a subset of 20-30 survey respondents) to explore decision-making in greater depth.

What is being tested

• Survey (other)
• Interview (other)

Sponsor: Thomas Jefferson University · Participants: 500 · Started: Dec 11, 2025

Contact the study team

• Munjireen Sifat, PhD, MPH · Phone: 267-432-2641

Official record on ClinicalTrials.gov — NCT07352579

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.